![](/img/cover-not-exists.png)
Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a ‘first in man’ Phase I investigation
Hermann Kain, David Goldblum, Bernard Geudelin, Eric Thorin, Christoph BeglingerVolume:
68
Year:
2009
Language:
english
Pages:
5
DOI:
10.1111/j.1365-2125.2009.03450.x
File:
PDF, 434 KB
english, 2009